Comparison of Two Empirical Antimicrobial Therapies of Prosthetic Joint Infection

NCT03850860 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2023-09-22

No results posted yet for this study

Summary

The empirical use of vancomycin in combination with a broad-spectrum beta-lactam is currently recommended after the initial surgery of prosthetic joint infection (PJI). However, the tolerability of such high-dose intravenous regimens is poorly known. T

Conditions

  • Bone and Joint Infection

Interventions

OTHER

empirical antibiotherapy

comparison of the outcome in the 2 groups having had 2 different empirical antibiotherapies

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Florent Valour, Md,PhD · HCL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-03-01
Completion
2019-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03850860 on ClinicalTrials.gov